Ishizawa Keisuke, Yoshizumi Masanori, Tsuchiya Koichiro, Houchi Hitoshi, Minakuchi Kazuo, Izawa Yuki, Kanematsu Yasuhisa, Kagami Shoji, Hirose Masao, Tamaki Toshiaki
Department of Pharmacology, University of Tokushima School of Medicine, Japan.
Hypertens Res. 2004 Jun;27(6):433-40. doi: 10.1291/hypres.27.433.
We previously found that human chymase selectively cleaves big endothelin-1 (ET-1) at the Tyr31-Gly32 bond and produces 31-amino acid endothelins, ET-1 (1-31), without any further degradation products. In this study, we investigated the effect of ET-1 (1-31) on the migration of cultured rat mesangial cells (RMCs) and on cells of the human monocytic cell line, THP-1. In addition, we examined the interaction between RMCs and THP-1 cells using conditioned media from ET-1 (1-31)-stimulated RMCs. ET-1 (1-31) caused an increase in RMC migration in a concentration-dependent manner, and the degree of increase was similar to those by ET-1 and angiotensin II (All). The ET-1 (1-31)-induced increase in RMC migration was inhibited by BQ123, an endothelin ETA receptor antagonist, but not by BQ788, an endothelin ETB receptor antagonist. ET-1 (1-31) alone did not cause significant migration of THP-1 cells. However, significant recruitment of THP-1 cells was observed with conditioned media taken from ET-1 (1-31)-stimulated RMCs. The conditioned media-induced migration of THP-1 cells was inhibited by BQ123, but not by BQ788. Western blotting analysis of the lysate of RMCs revealed that the expression of monocyte chemoattractant protein-1 (MCP-1) protein in RMCs was increased by treatment with ET-1 (1-31). The addition of neutralizing antibody for MCP-1 to the medium inhibited the migration of THP-1 cells induced by conditioned media from ET-1 (1-31)-stimulated RMCs. These findings suggest that ET-1 (1-31) play a role in glomerulonephritis (GN) via dual effects that directly cause the migration of mesangial cells (MCs) and may be responsible for the recruitment of mononuclear cells mediated through the activation of MCs. Since human chymase has been reported to be involved in glomerular disease, ET-1 (1-31) may be among the mediators.
我们之前发现,人糜酶可选择性地在Tyr31 - Gly32键处切割大内皮素 - 1(ET - 1),生成31个氨基酸的内皮素ET - 1(1 - 31),且无任何进一步的降解产物。在本研究中,我们调查了ET - 1(1 - 31)对培养的大鼠系膜细胞(RMCs)迁移以及人单核细胞系THP - 1细胞迁移的影响。此外,我们使用来自ET - 1(1 - 31)刺激的RMCs的条件培养基,研究了RMCs与THP - 1细胞之间的相互作用。ET - 1(1 - 31)以浓度依赖性方式导致RMCs迁移增加,增加程度与ET - 1和血管紧张素II(All)相似。内皮素ETA受体拮抗剂BQ123可抑制ET - 1(1 - 31)诱导的RMCs迁移增加,但内皮素ETB受体拮抗剂BQ788则无此作用。单独的ET - 1(1 - 31)不会引起THP - 1细胞的显著迁移。然而,从ET - 1(1 - 31)刺激的RMCs获取的条件培养基可观察到THP - 1细胞的显著募集。条件培养基诱导的THP - 1细胞迁移受到BQ123抑制,但不受BQ788抑制。对RMCs裂解物进行的蛋白质印迹分析显示,用ET - 1(1 - 31)处理可增加RMCs中单核细胞趋化蛋白 - 1(MCP - 1)蛋白的表达。向培养基中添加MCP - 1中和抗体可抑制来自ET - 1(1 - 31)刺激的RMCs的条件培养基诱导的THP - 1细胞迁移。这些发现表明,ET - 1(1 - 31)通过直接导致系膜细胞(MCs)迁移以及可能介导通过MCs激活募集单核细胞的双重作用,在肾小球肾炎(GN)中发挥作用。由于已有报道称人糜酶与肾小球疾病有关,ET - 1(1 - 31)可能是其中的介质之一。